Efficacy of switching to bilastine, a histamine H1 receptor antagonist, in patients with chronic spontaneous urticaria (H1-SWITCH): study protocol for a randomized controlled trial.
Atsushi FukunagaYoshiko OdaKen WashioTakashi OmoriYasumasa KakeiMichihiro HideChikako NishigoriPublished in: Trials (2020)
Japan Registry of Clinical Trials (jRCT), jRCTs051180105. Registered on 8 March 2019.